Ex vivo analyses of tumours, and in vitro studies on the MSTO-211H cells used in xenografts, showed induction of BH3-only proteins BIM and NOXA, which would account for the improved outcomes seen in the combination studies, as both of these proteins can potently inhibit MCL-1. This evidence concerns the gene MCL1 and neoplasm.